KCA
Search
- Page Path
- HOME > Search
Original Article
- Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
- Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik
- Cancer Res Treat. 2015;47(2):251-258. Published online October 27, 2014
- DOI: https://doi.org/10.4143/crt.2014.011
-
Abstract
PDF
PubReader
ePub - Purpose
In this study, we retrospectively investigated the prevalence of arterioportal (AP) shunts in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) and evaluated the changes in AP shunts after chemoembolization followed by external beam radiation therapy (EBRT).
Materials and Methods
We analyzed 54 HCC patients with PVTT who were treated with chemoembolization followed by EBRT. EBRT was uniformly delivered at a total dose of 30 to 45 Gy (median, 35 Gy), with a daily dose of 2 to 4.5 Gy. Angiographic images of chemoembolization before and after radiation therapy (RT) were reviewed to investigate the AP shunt.
Results
During the initial session of chemoembolization, 33 of 54 patients (61%) had an AP shunt. After EBRT, 32 out of 33 patients had an additional session of chemoembolization and were evaluated for a change in the AP shunt. The AP shunt decreased in 20 of 32 patients (63%) after chemoembolization followed by EBRT. The 1-year calculated overall survival (OS) rate for all patients was 52.6% and the 2-year OS was 36.4%. The median OS in all patients was 13 months. Patients with AP shunt showed poorer median OS than those without AP shunt, but there was no statistically significant difference (median, 12 months vs. 17 months).
Conclusion
The AP shunt frequently occurs in HCC patients with PVTT. This study suggests that a poor prognosis is associated with an AP shunt. Chemoembolization followed by RT may produce a decrease in AP shunts. -
Citations
Citations to this article as recorded by
- Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization
Wenzhe Fan, Bowen Zhu, Xinlin Zheng, Shufan Yue, Mingjian Lu, Huishuang Fan, Liangliang Qiao, Fuliang Li, Guosheng Yuan, Yanqin Wu, Xinhua Zou, Hongyu Wang, Miao Xue, Jiaping Li
Journal of Cancer Research and Clinical Oncology.2023; 149(5): 1873. CrossRef - Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Wenzhe Fan, Jian Guo, Bowen Zhu, Shutong Wang, Lei Yu, Wanchang Huang, Huishuang Fan, Fuliang Li, Yanqin Wu, Yue Zhao, Yu Wang, Miao Xue, Hongyu Wang, Jiaping Li
European Radiology.2021; 31(11): 8291. CrossRef - Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma
Ji Hyun Lee, Gyu Sang Yoo, Young Cheol Yoon, Hee Chul Park, Hyun Su Kim
Scientific Reports.2021;[Epub] CrossRef - Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case report
Yao-chang Luo, Hai-lin Lu, Wen-ling Song, Fei-fei Xuan
Journal of International Medical Research.2021;[Epub] CrossRef - Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin
Abdominal Radiology.2021; 46(11): 5417. CrossRef - Portal stent with endovascular brachytherapy improves the efficacy of TACE for hepatocellular carcinoma with main portal vein tumor thrombus
Tian Li, Chong Liu, Jin-Tong He, Kai-Da Sui, Zhou-Bo Zhang, Duo Hong, Hong-Ying Su, Hai-Bo Shao
Hepatobiliary & Pancreatic Diseases International.2020; 19(2): 187. CrossRef - Sorafenib Reduced Significantly Heptopulmonary Shunt in a Large Hepatocelullar Carcinoma
Philippe d'Abadie, Ivan Borbath, Pierre Goffette, Nadia Amini, Renaud Lhommel
Clinical Nuclear Medicine.2019; 44(1): 70. CrossRef - Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns
Mohammed Bermo, Manuela C. Matesan, Malak Itani, Fatemeh Behnia, Hubert J. Vesselle
Abdominal Radiology.2018; 43(11): 3001. CrossRef - Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors
L. Xiao, Q. Liu, W. Zhao, H. Pang, Q. Zeng, Y. Chen, J. Zhao, Q. Mei, X. He
Clinical Radiology.2018; 73(12): 1056.e17. CrossRef - Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors
Qiu-song Liu, Que-lin Mei, Yan-hao Li
European Journal of Radiology.2017; 89: 277. CrossRef - Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients
Lidia Sancho, Macarena Rodriguez-Fraile, Jose Ignacio Bilbao, Carmen Beorlegui Arteta, Mercedes Iñarrairaegui, Veronica Moran, Bruno Sangro
Journal of Vascular and Interventional Radiology.2017; 28(11): 1536. CrossRef - Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study
Jeong Il Yu, Jae Won Park, Hee Chul Park, Sang Min Yoon, Do Hoon Lim, Joon Hyeok Lee, Han Chu Lee, Seon Woo Kim, Jong Hoon Kim
Radiotherapy and Oncology.2016; 118(2): 408. CrossRef
- Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization
- 16,306 View
- 133 Download
- 14 Web of Science
- 12 Crossref
First
Prev
